O Bogunovic1, R Viswanathan. Show Affiliations » 1. Department of Psychiatry, State University of New York Health Science Center at Brooklyn 11203, USA.
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAntipsychotic Agents/adverse effectsAntipsychotic Agents/therapeutic useBenzodiazepinesBenztropine/adverse effectsBenztropine/analogs & derivativesBenztropine/therapeutic useFemaleHumansOlanzapineParasympatholytics/adverse effectsParasympatholytics/therapeutic usePirenzepine/adverse effectsPirenzepine/analogs & derivativesPirenzepine/therapeutic usePlatelet Count/drug effectsPsychotic Disorders/bloodPsychotic Disorders/drug therapyRecurrenceThrombocytopenia/chemically induced
Substances: See more » Antipsychotic AgentsParasympatholyticsBenzodiazepinesBenztropinePirenzepineOlanzapine
Year: 2000 PMID: 10849461 DOI: 10.1176/appi.psy.41.3.277
Source DB: PubMed Journal: Psychosomatics ISSN: 0033-3182 Impact factor: 2.386